GlassScriptPhysician profile
John B Dudley
NPI 1679923254
$11,071.44
in general payments reported to CMS, 2019-2025
25 companies · $4,277 in 2025
The $4,277 reported for 2025 was more than what 81% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $75.20 · 2020: $80.75 · 2021: $120 · 2022: $2,280 · 2023: $3,108 · 2024: $1,131 · 2025: $4,277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,206 · Consulting Fee: $2,750 · Travel and Lodging: $1,558 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,206.15 |
| Consulting Fee | $2,750.00 |
| Travel and Lodging | $1,558.30 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $3,991.24 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Edwards Lifesciences Corporation | $2,095.81 | 2023-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Pascal |
| Boston Scientific Corporation | $1,810.29 | 2022-2025 | Watchman Flx, Rhythmia Mapping System, Farapulse |
| Medtronic, INC. | $525.16 | 2021-2023 | Corevalve Evolut R |
| Abiomed | $473.72 | 2022-2025 | Impella |
| W. L. Gore & Associates, INC. | $341.78 | 2024 | Gore Cardioform Septal Occluder |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $236.28 | 2019-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $224.32 | 2023-2025 | Verquvo |
| Pfizer INC. | $213.55 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $200.20 | 2023-2025 | Camzyos, Eliquis |
| Penumbra, INC. | $184.21 | 2023-2025 | Penumbra System, Indigo System |
| Philips North America LLC | $173.44 | 2022-2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Kestra Medical Technology Services, INC. | $103.90 | 2023-2025 | Assure Wcd |
| Novartis Pharmaceuticals Corporation | $79.24 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $66.37 | 2022-2023 | Farxiga |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $56.38 | 2023-2025 | Repatha, Repatha |
| Cardiva Medical, INC. | $50.17 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Janssen Pharmaceuticals, INC | $45.23 | 2022 | |
| Lantheus Medical Imaging, INC. | $43.10 | 2022-2025 | |
| Abbott Laboratories | $42.64 | 2023-2025 | Amplatzer Amulet, Xience Skypoint |
| Teleflex LLC | $30.66 | 2025 | Orsiro Mission |
| Biosense Webster, INC. | $26.23 | 2025 | Carto 3 |
| Cvrx, INC. | $25.84 | 2024 | Barostim Neo System |
| Biotronik INC. | $18.48 | 2022 | |
| Scpharmaceuticals INC. | $13.20 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Dudley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.